drugset / Trial / NCT05327556
Epinephrine in the Pediatric Intensive Care Unit: A Dose-Effect Trial
Phase 2
Terminated
15 enrolled
Boston Children's Hospital
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The use of peri-arrest bolus epinephrine (PBE) has emerged as a rescue strategy for life-threatening hypotension in pediatric intensive care units (ICU) despite scant published data supporting its use in this setting. As optimal dosing of PBE in this population is unclear, we aim to determine if an initial dose of 0.5 mcg/kg versus 1.0 mcg/kg yields differences in hemodynamic outcomes. The EPI Dose Study is a single-center, prospective, randomized, double-blind, dose-effect trial measuring systolic blood pressure (SBP) before and after PBE is given. We hypothesize that the 1.0 mcg/kg group will have more robust increases in SBP.
Timeline
- Start
- 2023-02-08
- Primary completion
- 2025-05-16
- Completion
- 2025-05-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Epinephrine | Other / unclassified | 0.5 ug/kg | — |
| Comparator | Epinephrine | Other / unclassified | 1 ug/kg | — |